Author:
Wang Junyu,Wu Zongmei,Xia Mengmeng,Salas Sandra Serna,Ospina Johanna Arroyave,Buist-Homan Manon,Harmsen Martin C.,Moshage Han
Funder
China Scholarship Council
Stichting De Cock-Hadders
Saudi Spine Society
Consejo Nacional de Ciencia y Tecnología
Reference39 articles.
1. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement, lancet;Eslam;Gastroenterol. Hepatol.,2021
2. International consensus, MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease;Eslam;Gastroenterology,2020
3. NAFLD: a multisystem disease;Byrne;J. Hepatol.,2015
4. ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials;Calle;Nat. Med.,2021
5. Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management;Huang;Intern. Med. J.,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献